Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. InfuTronix LLC
WARNING LETTER
•InfuTronix LLC•February 15, 2022

InfuTronix LLC – FDA Warning Letter, Feb 15, 2022

Record Details

The FDA issued a Warning Letter to InfuTronix following an inspection from January 29 to February 15, 2022, at their Natick, MA facility, which manufactures infusion pumps and administration sets. The inspection revealed that the firm's devices are adulterated under 21 U.S.C. § 351(h) due to non-conformity with Quality System (QS) regulation (21 CFR Part 820) and misbranded under 21 U.S.C. § 352(t)(2) and § 352(o).

Significant QS violations include failure to analyze quality data and employ statistical methods for recurring problems (21 CFR 820.100(a)(1)), inadequate complaint handling procedures (21 CFR 820.198(a)), and failure to investigate device failure complaints (21 CFR 820.198(c)). Additionally, the firm failed to report a correction/removal of Nimbus II PainPRO pumps with an unreleased library configuration within 10 days (21 CFR 806.10) and lacked adequate Medical Device Reporting (MDR) procedures (21 CFR 803.17). Furthermore, InfuTronix Administration Sets were found adulterated and misbranded because significant design and labeling changes were made post-510(k) clearance without new premarket approval or notification (21 U.S.C. § 360e(a), § 360(k)).

Despite multiple responses from the firm outlining corrective actions, the FDA deemed them inadequate as actions were incomplete and timelines undefined. InfuTronix must provide a comprehensive response within 15 business days detailing specific, systemic corrective actions, supporting documentation, and a timetable. Failure to comply may result in regulatory actions such as seizure, injunction, civil penalties, and impact on federal contracts or device approvals.

Company
InfuTronix LLC
Inspection date
February 15, 2022
Product type
Devices
Office
Office of Medical Devices and Radiological Health Operations Div. 1 East
People
  • Joseph S. Matrisciano (Program Division Director)
  • Courtney H. Lias (Acting Director)
View Company Profile

ID · e5df945b-61ed-444f-980d-415f93daeb0f

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.100(a)(1)21 CFR 820.198(a)21 CFR 820.198(c)21 U.S.C. 352(t)(2)21 U.S.C. 360i21 CFR 80621 CFR 806.10

Full citation text and observation details available on the Dashboard.

Other documents for InfuTronix LLC
  • 483 - 2023-08-16August 16, 2023
  • 483 - 2022-02-15February 15, 2022
  • EIR - 2018-04-05April 5, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore InfuTronix LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.